Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Vorinostat with Chemotherapy for Relapsed Pediatric ALL
NCT01483690Phase 2Terminated
- Sponsor
- Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
- Start
- Dec 2011
- Primary completion
- Jul 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of decitabine, vorinostat in acute lymphoblastic leukemia (ALL), sponsored by Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium. Started Dec 2011; status: terminated.
02
Drugs
decitabinevorinostat
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01483690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483690.